While various approaches have been proposed in clinical trials aimed at improving motor function after spinal cord injury in humans, there is still limited information regarding the scope, methodological quality and evidence associated with single-intervention and multi-intervention approaches. A systematic review carried out using the PubMed search engine and the keywords "spinal cord injury motor recovery" identified 1,973 records, of which 39 were selected (18 from the search records and 21 from reference list inspection). Study phase (clinicaltrials.org criteria) and methodological quality (Cochrane criteria) were assessed. Studies included proposed a broad range of single-intervention (encompassing cell therapies, pharmacology, electrical stimulation, rehabilitation) (encompassing cell therapies, pharmacology, electrical stimulation, rehabilitation), and multi-intervention approaches (that combined more than one strategy). The highest evidence level was for phase III studies supporting the role of multi-intervention approaches that contained a rehabilitation component. Quality appraisal revealed that the percentage of selected studies classified with high risk of bias by Cochrane criteria was as follows: random sequence generation=64%; allocation concealment=77%; blinding of participants and personnel=69%; blinding of outcome assessment=64%; attrition=44%; selective reporting=44%. The current literature contains a high proportion of studies with a limited ability to measure efficacy in a valid manner due to low methodological strength in all items of the Cochrane risk of bias assessment. Recommendations to decrease bias are discussed, and include increased methodological rigor in the study design and recruitment of study participants, and the use of electrophysiologic and imaging measures that can assess functional integrity of the spinal cord (and may be sufficiently sensitive to detect changes that occur in response to therapeutic interventions).
Introduction
It is estimated that 30 individuals sustain an injury to the spinal cord every day in the United States. 1 There are approximately 2 million people living with the consequences of SCI worldwide, a relatively low number thought to reflect the higher mortality associated with acute SCI in developing countries. 2 Injury to the spinal cord greatly disrupts information between the supraspinal centers and muscles, leading to varying degrees of paralysis that greatly impact one's functional ability and quality of life.
Despite the great advances in clinical management (including surgical decompression of the spinal cord, pharmacology and rehabilitation) and investigational efforts, recovery of motor function is still considered limited. The International Standards for Neurological Classification System for Spinal Cord Injury (ISNCSCI) developed by the American Spinal Injury Association (ASIA) 3, 4 is the most widely system for the classification of residual neurologic function after SCI. According to the ISNCSCI, approximately 55% of cases are incomplete (i.e., presence of varying degrees of sensory or motor activity below the neurological level of injury) and in the remaining 45% of cases, there is no sensory and/or motor function in the S4-5 sacral segments (classified as motor-complete) as determined by the motor and sensory testing.
Traditionally in SCI research, potential therapeutic approaches targeting motor-incomplete lesions focus regeneration due to many factors, including the limited axonal growth response that is due to the presence of many molecules in the myelin debris and glial scar tissue that cause growth cone collapse. 6 In addition to the challenges imposed by the lesion itself, the success of potential therapeutic approaches has been linked to the adoption of better practices in scientific design, methodology of research studies, and the development of sensitive outcome measures of spinal cord integrity and residual connectivity. 2 These have to complement improved clinical assessments to better characterize the effects of the injury on the nervous system and changes that occur in response to therapeutic interventions. 2, 7 In addition, the use of combinatorial approaches 8,9 may be more effective than single-intervention approaches by simultaneously targeting different injury mechanisms. There is recent promising evidence demonstrating recovery of stepping in rats with a transected spinal cord after a combinatorial approach incorporating locomotor training with electrical neuromodulation and a pharmacology agent. 10 However, there have not been many practical efforts in this direction in humans.
The aims of this review were to: 1) perform an appraisal of the methodology of studies targeted at improving motor function in individuals with acute and chronic SCI; 2) identify the scope and evidence level associated with single-intervention (encompassing cell therapies, pharmacology, electrical stimulation, rehabilitation) and multi-intervention approaches (that combined more than one strategy) published in the literature to date; 3) identify the number of studies that incorporated an evaluation of spinal cord integrity and residual connectivity; 4) describe potential sources of bias in the selected studies; 6 A filter was applied to limit the search to studies performed in humans. Studies were considered for eligibility if they were written in English and were published from 1990 until the search date (01/10/14).
The remaining criteria for inclusion and exclusion can be seen on Table 1 , and the protocol for the present review is publicly available. 11 Abstracts were screened for eligibility, and relevant studies were reviewed in full by two independent trained examiners (JGO and MC), and discrepancies were resolved in monthly meetings with a third author (APL). Reference lists of the included articles were screened to identify potential articles not captured by the initial search.
<<<<<<<<Insert Table 1 here>>>>>>>>> This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. 12 Data extraction of the included studies was done in adherence to the population intervention comparison outcome (PICO) framework, 12 wherein recommended study characteristics were collected (Methods, Interventions, Participants and Outcomes) utilizing the Revman 5 software (version 5.1, Cochrane Collaboration, Canada) and tables utilizing Excel (Microsoft, USA). A semi-quantitative analysis was performed by classifying studies according to the approach used (Cell therapy, Pharmacology, Rehabilitation, Electrical Stimulation/Neuroelectric device, Combinatorial), stage of SCI (acute/subacute=study enrollment within minutes to 12 months post-injury; and chronic=study enrollment after 12 months post-injury) and the absence/presence of an assessment of spinal integrity/residual connectivity. Studies were classified according to the phase as per clinicaltrial.org criteria ( Table 2 ). Study quality appraisal and risk of bias assessment were performed as per the Cochrane Handbook for Systematic Reviews and Interventions. 13 A "risk of bias " table was constructed with all included studies, containing a description and judgment (low risk, high risk or unclear risk) for the following potential sources of bias: 1) random sequence generation; 2) allocation concealment; 3) blinding of participants and personnel; 4) blinding of outcome assessment; 5) incomplete outcome data; 6) selective reporting; 7) other sources of bias. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
<<<<<<<<Insert Table 2 here>>>>>>>>>
Results
The first and second searches yielded 1,973 results ( Figure 1 ). Upon examination, 1,931 citations that were not relevant to the topic, reviews or opinion articles were excluded. Upon further examination, 24 articles (18 that did not fulfill our inclusion criteria and 6 articles that were not classifiable) were excluded. Eighteen full text articles met the inclusion criteria. Within the process of the review, twentyone additional studies, which pertained to the topic but were not identified in the PubMed search were included in the study, resulting in the inclusion of 39 full-text articles.
<<<<<<<<Insert Figure 1 here>>>>>>>>> Quality assessment for all studies included can be seen in Figure 2a , and individualized scoring of each study for multiple sources of bias assessed is displayed in Figure 2b . Fourteen publications (36%) had low risk of bias and the remaining 25 studies (64%) had high risk of bias for random sequence generation.
Nine studies (23%) adopted and reported methods of allocation concealment, whereas 30 studies (77%) were at high risk of bias. Twelve studies (31%) adopted and reported blinding methods for the participants and personnel, whereas 27 studies (69%) were associated with high risk of bias. Fourteen studies (36%) adopted and reported methods for blinding of outcome assessment and thus, were at low risk for bias from this source. The remaining 25 studies (64%) did not adopt or report methods for minimizing bias arising from outcome assessment. Twenty-two studies (56%) reported and the remaining <<<<<<<<Insert Figures 2a and 2b here>>>>>>>>> Figure 3 displays the studies according to the time since injury (acute/subacute and chronic SCI) and study phase (I-IV). It can be seen that 37.5% of studies in the acute stage were phase I, 18.8% were phase II and the remaining 43.8% were phase III. In the chronic stage, 27.3% of studies were phase I, 13.6% were phase II, and 59.1% were phase III studies. There were no phase IV studies. Figure 4 displays the approaches utilized in each study stage, for both acute and chronic SCI.
<<<<<<<<Insert Figure 3 here>>>>>>>>> Twelve studies 14-22 assessed spinal integrity using magnetic resonance imaging (MRI) ( Tables 3 and 4 ).
Five studies limited the inclusion criteria based on the MRI findings. Two studies proposed limits in the lesion size, 18, 19 one study excluded participants depending on the presence of tethering in the spinal cord, 23 and two studies excluded individuals who had complete transections. 15, 24 Ten studies assessed spinal cord residual connectivity utilizing motor evoked potentials acquired with TMS. 14, 17, 19, 21, [25] [26] [27] [28] [29] <<<<<<<<Insert Tables 3 and 4 here>>>>>>>>> Approaches utilized in acute/subacute SCI Several approaches have been proposed in phase I studies in acute SCI (Table 3, Figure 4 ). Cethrin, a compound that decreases the activity in the rho pathway (involved in the growth cone collapse after central nervous system injury) was tested in one study. 30 Raffinee, a drug with free-radical scavenging properties has also been evaluated. 31 An electrical stimulation/neuroelectric device that consisted of an implanted oscillating electric field intended to guide neurite growth was also assessed in a study. 24 The remainder of phase I studies have focused on cell therapies, resulting from reports of successful outcomes in experimental models of SCI. These included: cell transplantation of bone-marrow derived mesenchymal stromal cells, 15 autologous activated Schwann cells, 16 and autologous activated macrophages. 17
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Grossman et al 32 carried out a phase II study to assess the feasibility, safety and preliminary efficacy of riluzole, a sodium-channel blocking medication shown to excitotoxicity and improve outcomes of motor function in animal models of SCI (and with an established safety profile in humans). Twenty-four individuals with SCI (AIS A-C, within 12 hours post-injury) received 50 mg of riluzole (twice daily, for 14 days, enteric administration). Comparisons were made with a database control group, matched for gender, age and neurological injury level. Individuals who received riluzole made significantly greater improvements in AIS motor scores at a 6 months follow-up, when compared with the database control. Sixteen participants injured less than 48 hours prior to study enrollment received an intravenous dose of 10μg/kg/day for 5 consecutive days and demonstrated significant improvements in ASIA Impairment Scale (AIS) motor scores on the follow-up assessment performed 3 months later when compared to the pre-intervention assessment. However, no significant differences were found when comparisons were made to a database control group. 33 In a latter study in 37 participants with incomplete cervical SCI, Inada et al 34 found that the same dose of G-CSF as used by Takahashi et al 33 was associated with greater improvements in AIS motor scores than a control group at one year post-transplantation. Unfortunately, participants were allocated to the experimental group based on the institution they were treated at (in a non-randomized manner), and it was possible to assess if clinical management differed between the sites. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
between-group differences in AIS scores, Functional Independence Measure (FIM) Scores and Spinal
Cord Independence Measure (SCIM) between those treated with minocycline and placebo for up to one year post-intervention. 35 Following evidence suggesting that dopamine can improve motor task acquisition, Maric et al 36 carried out a cross-over study to compare the effects of L-dopa and placebo.
Twelve participants received L-Dopa (200 mg L-Dopa, 5 days per week for 6 weeks) or placebo prior to physical therapy (45 minutes, twice daily for 6 weeks) and there were no differences between the outcomes between the two groups after 12 weeks (AIS scores, FIM, WISCI-II [walking index for SCI]). 36 Kumru et al 25 performed a phase III study to assess the influence of non-invasive brain stimulation delivered in the form of high-frequency repetitive transcranial magnetic stimulation (rTMS), aimed at facilitating corticospinal excitability. Seventeen participants who had had a SCI between 3 and 12 months prior to study enrollment received rTMS or sham-rTMS (15 sessions, 5 days per week for 3 weeks) and engaged in a rehabilitation protocol for 5 hours per day, 5 days per week for 5 weeks. 25 There were no between-group differences, but pre-post changes reached significance for gait speed and lower extremity This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Two phase III studies assessed Chinese Medicine approaches. Wong et al 39 enrolled individuals who were injured at approximately 2 months and compared the outcomes of a group that received standard rehabilitation program in isolation with a group that additionally received electro-acupuncture targeting the Governic meridian. At the end of one year, the authors found significant pre-post changes in AIS scores in both groups, but only the acupuncture group exhibited significant pre-post changes in the FIM. 39 Li et al 40 performed a phase III study to assess the influence of Di Huang Yin Zi (DHYZ), a pharmacological approach with unclear mechanisms, in 60 individuals with acute SCI (approximately 4 weeks post-injury). Participants received either DHYZ or placebo (18 grams, twice daily) for 12 weeks, and authors reported greater increases in AIS motor scores in the DHYZ group when compared with placebo. 40 Approaches in chronic SCI Table 4 lists all included studies in chronic SCI. There were a total of 6 phase I studies. Lima et al 18 proposed the transplantation of olfactory mucosal autografts into the chronically injured spinal cord. A second independent study proposed the use of olfactory entheathing cells. 19 Yazdani et al 23 proposed a combinatorial approach that consisted of cell transplantation of bone-marrow mesenchymal stromal cells and Schwann cells, combined with rehabilitation. The remaining phase I chronic studies included a rehabilitation study that assessed automated locomotor training using a position-controlled gait-driven orthosis, 41 an impedance-controlled robotic orthosis, 42 and a study that assessed the effects of bodyweight supported treadmill training combined with electrical stimulation. 43 Segal et al 44 carried out a phase II study to assess the effects of 4-aminopyridine, a potassium-channel blocker that has been associated with improved axonal conduction, particularly in demyelinated nerve fibers. Participants (various AIS grades) were randomized to a 3 month regimen of 4-aminopyridine, either delivered in the form of a low dose (6mg/day) or a high dose (30mg/day). 44 Comparisons were This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
made with an unblinded group that received a high dose (30mg/day). The authors reported significant prepost increased AIS motor scores, only when all groups were collapsed together. 44 One phase II study has assessed the effect of locomotor training in 225 individuals who had sustained a chronic incomplete SCI and also examined the effects of a combinatorial approach consisting of manual facilitated body weight-supported step training on a treadmill and community reintegration. 45 The dose was variable, based on the participant's ambulatory capacity (5 times/week for non-ambulatory participants, 4 times/week for participants who required pronounced assistance and 5 times/week for ambulatory participants). After having completed a mean of 60.3±53.24 sessions, the authors found significant pre-post improvements in the following outcome measures: LEMS, upper extremity motor scores (UEMS), 6-minute walk (speed and distance), and 10-meter walk (speed). In addition, using preestablished functional walking stratifications, 46 33% of non-ambulatory participants became walkers, 47% of slow walkers improved to faster walkers, and overall AIS conversion rates from C to D was 28% (for AIS classification, see Table 1 ). 45 Four studies assessed the effects of combinatorial approaches for upper extremity function improvement.
One phase II study assessed the effects of a single-session of transcranial magnetic stimulation paired with electrical stimulation on fine motor hand performance in 10 individuals with chronic SCI and found significant improvements on the Nine-Hole Peg Test measured at 20 minutes and 30 minutes poststimulation. 26 A phase III study assessed the effects of task specific training (2 hours/day, 5 days a week for 3 weeks) delivered in isolation or combined with electrical stimulation of the median nerve in 24 participants, and found greater improvements in hand motor performance in the combined approach. 27 In a latter study with the same sample size, the authors found that the combination of task-specific training and electrical stimulation was associated with significantly larger improvements in hand motor performance than either intervention used in isolation. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
The combination of task-specific training and electrical stimulation was further investigated by Hoffman et al. 29 In this phase III study, investigators compared the effects of functional electrical stimulation to submotor threshold electrical stimulation, each combined with either unimanual or bimanual task-specific training, utilizing the same dose and sample size (n=24) as in the prior studies. 29 This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
documented treatment time was 89±22.1 hours. 50 At post-test, there were significantly greater improvements in the ABT condition on AIS motor scores, LEMS, walking speed (10 meter walk) walking distance (6-minute walk), and on the Spinal Cord Injury Functional Ambulation Index. 50 Five studies assessed the effects of cell therapies, in isolation or combined with rehabilitation attributed these results to the lack of a rehabilitation protocol. 21 Lima et al 20 assessed the influence of olfactory mucosal autografts and locomotor training in 20 participants with complete SCI. All participants engaged in rehabilitation (mean=31.8±6.8h/week for 34.7±30 weeks) prior to and following (32.7±5.2 h/week for 92±37.6 weeks) the olfactory mucosal autograft transplant. 20 The authors found pre-post improvements in LEMS and walking function (FIM and WISCI). 20 In addition, 15/20 participants (all whom had sustained motor-complete injuries) demonstrated electromyography activation below the level of injury, leading the authors to conclude that there was late neurological recovery. 20 Larson et al 51 carried out a phase III study to compare outcomes of participation in an intense rehabilitation program between individuals with and without a history of a previous olfactory mucosal 51 With all groups collapsed, there were significant improvements in AIS scores at 60 days post-intervention, and no differences were found between those who received olfactory mucosal cell transplant and those who did not. 51 The authors concluded that the intense rehabilitation approach was likely a key factor responsible for the functional improvements. 51 Kishk et al 22 assessed the effects of transplantation of flask-adherent bone marrow stromal cells and rehabilitation in individuals who had a SCI at least 6 months prior to study enrollment. Forty-four participants with variable injury levels and severity received mononuclear cells (dose: 5 × 10 6 to 10 × 10 6 /kg, administered intrathecally every month for 6 months), and 20 participants who did not agree to study procedures comprised the control group. 22 All individuals participated engaged in rehabilitation 2-3 times/week. 22 The authors found that the intervention group made significantly greater gains in AIS scores, but the amount of improvement was correlated with having an incomplete injury. Since the groups were not balanced for injury severity, this finding was of limited clinical value. 22 One study assessed the combination of daily intermittent hypoxia (Daih) and rehabilitation on locomotor outcomes in SCI. 52 Using a double-blind, randomized crossover study, Daih (15-90 second intervals, fraction of inspired oxygen=0.9 for 5 days) or Daih-Sham were delivered in isolation or combined with subsequent walking training, in 19 individuals with incomplete SCI. 52 The authors found that Daih increased walking speed (measured by the 6-minute walk) one day and two weeks post-administration.
Furthermore, the combination of Daih and walking training was associated with greater improvements in This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Discussion
A systematic assessment of the literature reveals that various strategies have been proposed to improve motor function after spinal cord injury (including Cell therapy, Pharmacology, Rehabilitation, Electrical Stimulation/Neuroelectric device (delivered individually, or in combinatorial approaches containing each of these strategies). The highest evidence level available (level III) supports combinatorial approaches that contained a rehabilitation component. Quality appraisal of the included literature highlights that there are still few well-designed studies producing high-level evidence that can appropriately answer questions regarding the effectiveness of many approaches proposed. Among the sources of bias encountered, the most concerning were: the inclusion of highly heterogeneous samples; the lack of randomization and concealed allocation procedures; the absence of blinding procedures; and the use of outcomes with limited sensitivity. In addition, only few studies included measures of integrity and residual connectivity of spinal pathways.
The finding that combinatorial approaches comprised 43% of phase III studies in acute SCI and 77% of studies in chronic SCI is encouraging. Wenger et al 10 demonstrated meaningful functional recovery of stepping in rats after a transection to the spinal cord following 4 weeks of body-weight supported treadmill training delivered in combination with electrical neurostimulation and serotonin agonists administered systemically. Our study of the human literature supports this experimental evidence 10 by demonstrating that the strongest evidence for improved outcomes of motor function comes from trials that employed combinatorial approaches containing a rehabilitation component. 25, [27] [28] [29] 38, 39, 48, 49 Taken together, we believe that future clinical trials have greater potential for motor recovery if novel therapeutic strategies (such as neurostimulation and pharmacotherapy) are tested as adjuvant to rehabilitation.
The paucity of high-level evidence of studies from other modalities (including cell therapies, pharmacology, electrical stimulation/neuroelectric devices) should not be interpreted as a lack of effectiveness. Instead, this is partially an encouraging finding that reflects the high productivity in SCI This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. research in the last 17 years, characterized by increases in the number of phase-I and phase II studies suggesting promising novel treatment strategies. While the main objective of phase I and II trials is the assessment of safety and feasibility of a given intervention, many methodological concerns with the early stage trials were identified, and future trials need to be more carefully designed, in order to allow for inferences regarding preliminary efficacy that are useful in planning phase III studies.
The inclusion of participants with broad age range and diverse clinical characteristics (time since injury, injury severity) introduces insurmountable heterogeneity that is concerning when inferences regarding recovery are drawn based on group data. Spontaneous recovery rates have been shown to differ considerably based on the level and severity of the injury. There is evidence to support that as many as
10% of individuals with complete (AIS A injuries) will convert to AIS C and D (incomplete injuries)
within the first year in the absence of any therapeutic intervention. 2 For those initially classified as AIS B, 15-40% will convert to AIS C, and approximately 40% of the remaining will convert to AIS D. 2 Eighty percent of individuals initially classified as AIS C will convert to AIS D within the first year. 2 In our opinion it is critical that future studies restrict the inclusion criteria to create homogeneous groups especially in studies enrolling individuals with acute and subacute injuries. 53 In studies with larger sample sizes, another option is to perform statistical analyses based on AIS level at entry. 38 Furthermore, nearly all studies used the ISNCSCI criteria as the primary outcome measure for neurologic recovery. While the AIS exam is the most widely used neurologic classification for SCI, it has a considerable degree of subjectivity, and requires formal training for the investigators/clinical staff in order to achieve optimal rates in terms of intra-rater and test-retest reliability 54 (although rarely reported in the studies assessed). We found that 69% of the studies included did not adopt blinding of participants, and 64% of studies did not adopt blinding procedures for the investigators. This is an important concern, because when recovery occurs, we often do not know why it happens due to the lack of mechanistic discriminative power of our clinical assessments. It is thus important to develop measures that allow change in particular pathways to be detected. Spinal cord integrity and residual connectivity was only This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. assessed in a few number of studies (28% and 26%, respectively). Given its importance in motor function, the development of sensitive outcome measures of viability of corticospinal pathways is an important direction given the limited sensitivity of currently available outcome measures to quantify neurologic impairments and changes that may occur in response to novel therapies.
We believe that such neurophysiologic and neuroimaging measures should be used to characterize spinal cord structure and physiology of the injury in future clinical trials. Potential approaches for assessing corticospinal conduction may involve the use of noninvasive or minimally invasive brain stimulation, electrophysiology and imaging techniques. 7 For example, the quantification of motor evoked potentials elicited with TMS enables the assessment of functional integrity of the corticospinal tract, spinal nerve roots and motor pathway's projections to the muscles. 55 Moreover, more advanced TMS protocols, particularly the triple-pulse protocol that combines central and peripheral stimuli, enable accurate quantification of the number of corticospinal fibers with preserved conduction across a putative spinal injury level. 56 Finally, such neurophysiologic studies can be combined with diffusor tension imaging and other advanced imaging methods, 57 to provide anatomical characterization of the structural integrity of the corticospinal tract, including alterations in fractional anisotropy (that assesses the axonal count and myelin content), axial diffusivity and radial diffusivity (that assesses the integrity of axons and myelin). 7 Our search strategy captured only 18 or the 39 included articles. This can be explained by the difficulty in designing a search that identifies all of the different interventions of interest without requiring the need to review many thousands of abstracts. Although we employed multiple queries and inspected reference lists, it is possible that the search strategy employed herein may have been insufficient to detect all published studies for each approach (cell therapies, pharmacology, electrical stimulation, rehabilitation).
Another limitation is that we did not include studies that assessed surgical decompression, which is a strategy with established efficacy. 58 In addition, the use of the Cochrane criteria of risk of bias may have resulted in a stringent evaluation of Phase I studies. While we acknowledge that the Cochrane criteria were primarily developed for application to randomized clinical trials, we felt it offered valuable insights. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Conclusions
Future research will benefit from addressing the methodological and conceptual concerns highlighted in the present study. The highest available evidence supports the use of combinatorial approaches containing Table 1 . Inclusion and exclusion criteria used in the present study. SCI=spinal cord injury. Table 2 . Criteria used to classify study phase (I, II, II, IV, from clinicaltrial.org). Table 3 . Approaches used in Acute/subacute SCI. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
Interventions
Cell therapies, pharmacology approaches, Electrical stimulation/neuroelectric devices, rehabilitation or a combination therapies including any of the above strategies.
Studies that: were not designed to assess the effects of an intervention (observational studies, studies carried out to assess an outcome measure); did not include a performance-based measure of motor function; assessed gangliosides and methylprednilosone, surgical decompression of the spinal cord, or were not available in full-text.
Comparisons of interest
Intervention versus active or inactive control; Pre-intervention/Postintervention (for studies that did not include a control group)
None
Study design
Studies with an active control group (comparison group) were preferred, but studies with inactive controls (placebo or wait-list control), and safety/feasibility studies were also included.
Observational studies; Studies carried out using retrospective analysis of clinical findings and studies with no original data (reviews)
Timing/Setting Longitudinal studies that occur in general and clinical settings None Table 1 . Inclusion and exclusion criteria used in the present study. SCI=spinal cord injury. as been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from Table 2 .
Study Phase
Description I Study carried out to assess a new approach in a small sample for the first time to evaluate its safety, determine a safe dosage range, and identify side effects II Approach is given to a larger sample to see if it is effective, further evaluate safety and determine optimal dose III Approach is to a large sample to confirm effectiveness, monitor side effects, make comparisons to commonly used treatments, and collect information that will allow the approach to be used safely
IV
Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use Table 2 . Criteria used to classify study phase (I, II, II, IV, from clinicaltrial.org).
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